This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Barry C. Gibney is a thoracic surgeon at the Medical University of South Carolina and Hollings Cancer Center in Charleston, South Carolina. He specializes in leading-edge treatments and minimally invasive robotic surgery for patients diagnosed with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies. He is thankful that the development of immunotherapy and improved use of chemotherapy in combination with minimally invasive surgical procedures has provided patients with better outcomes and drastically improved survival rates.
At the Hollings Cancer Center, Dr. Gibney works as part of the lung and thoracic cancer team with thoracic oncologists, pulmonologists, and radiation oncologists, exchanging ideas between the disciplines to provide patients with individualized treatment plans that are best suited to their conditions and their needs. He also says that providing care for end-stage lung disease patients is an important part of his role at Hollings, and requires a team approach. Dr. Gibney’s special interest is in esophageal cancer and minimally invasive thoracic surgery.
Education and Career
Dr. Gibney earned a bachelor of science degree in Psychology at the University of Florida, then completed the first phase of his medical education at the Nova Southeastern University College of Osteopathic Medicine. He completed his internship and residency at the Penn State Milton S. Hershey Medical Center. He also pursued surgical research at Brigham and Women’s Hospital and completed a fellowship in Thoracic Surgery at Brigham and Women’s Hospital/Children’s Hospital at Harvard Medical School in Boston.
Dr. Gibney’s published research can be found on the National Institutes of Health PubMed website, and includes:
Wedge resection-finding its place in early-stage non-small cell lung cancer? Morgan A Hill, Barry C Gibney>; Journal of Thoracic Disease. 2023 Jun 30
Waitlist and Transplant Outcomes in Organ Donation After Circulatory Death: Trends in the United States. Jennie H Kwon, Walker M Blanding, Khaled Shorbaji, Joseph R Scalea, Barry C Gibney, Prabhakar K Baliga, Arman Kilic>; Annals of Surgery. 2023 Oct 1
Cancer-Directed Surgery for Mesothelioma: A Team Sport. Barry C Gibney, Frank C Detterbeck> ; Chest. 2023 May 1Get Your FREE Mesothelioma Packet
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.